A tubule cell model for ifosfamide nephrotoxicity

Area of Science:

• Nephrology
• Pharmacology
• Biochemistry

Background:

• Ifosfamide (IF) is a chemotherapy drug known to cause kidney damage.
• The precise mechanisms of IF-induced nephrotoxicity are not fully understood.
• Localized metabolism of IF in renal tubules and production of chloroacetaldehyde are suspected contributors.

Purpose of the Study:

• To create a renal tubule cell model for studying IF nephrotoxicity.
• To determine if renal proximal tubular cells possess the necessary cytochrome P450 (CYP) enzymes for IF metabolism.
• To investigate if these cells can metabolize IF into nephrotoxic chloroacetaldehyde.

Main Methods:

• Utilized LLCPK-1 cells as a tubule cell model.
• Detected CYP3A and CYP2B mRNA and protein expression.
• Analyzed the metabolism of R- and S-IF enantiomers and assessed cell viability.
• Investigated the role of glutathione depletion in IF toxicity.

Main Results:

• CYP3A and CYP2B enzymes were identified in LLCPK-1 cells.
• These cells metabolized IF enantiomers to dechloroethylifosfamide metabolites, indicating chloroacetaldehyde formation.
• Metabolite production was dependent on time and concentration.
• IF did not impact cell viability, but glutathione depletion led to significant cell damage.

Conclusions:

• Renal tubular cells possess the CYP enzymes capable of metabolizing IF.
• Localized production of chloroacetaldehyde in renal tubules likely contributes to IF-induced nephrotoxicity.
• Glutathione plays a critical role in defending against IF toxicity.
• Pharmacological strategies aimed at increasing intracellular glutathione levels may mitigate IF-induced kidney damage.